Hiring?
Logo

Patented AntiVirus Agent

location_on

Singapore, Singapore

Short Summary

Our Patented Antimicrobial Agent, trademarked Rozinco, protects all surfaces with a residual effect that prevents the growth of microbes. Rozinco is a self-powered, powder sized micro-factory that emits oxidising agents which kill microbes.

Overview

Target
S$1,500,000
Minimum
S$20,000
Investment Raised
S$500,000
Previous Rounds S$500,000
Stage MVP/Finished Product
Investor Role

Highlights

  • Owns a worldwide patented antibacterial, antifungal, antiviral technology
  • Many products ready for commercialization to meet COVID protection demand
  • Generating revenue since 2019
  • Rozinco has several verifications on the efficacy
  • Already raised S$500k+
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
31% raised

MyCLNQ-Health(Video/Tele)

location_on Singapore, Singapore

MyCLNQ-"Connecting all your Healthcare needs" (betterment of community) MyCLNQ has full suite of Tele Health (Video/Tele/House call/Chat); Medical Transport booking; Digital booking for Medical caregiver (Escort/Companion/Nursing) and Home Therapy.

S$ 800,000

Target

S$ 100,000

Min per Investor

Global Pro
0% raised

AI-diagnostic skincancer

location_on Sweden,

QMedTech is a MedTech CO. that utilizes Quantum AI algorithms to detect and diagnose skin cancer at its earliest stages. Our goal is to deliver a solution that adapts and learns while bringing a reliable and trustworthy result to users every time.

S$ 6,200,000

Target

S$ 15,000

Min per Investor

Featured
94% raised

Nocira Migraine Device

location_on South West, USA

Nocira migraine device: pain relief via gentle ear pressure changes = far more effective vs current drugs/devices, safe, consumer-friendly, easy/pleasant to use; 4 trials, 100+ patients; 150+yrs experienced leaders; major KOL champions; $8+M raised

S$ 10000000

Target

S$ 14,000

Min per Investor

load one similar proposal